SEC Tracker
Get the app

PAVmed PAVM

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Completes an acquisition or sale of assets (2.01)
  • Reports an exchange listing deficiency notice (3.01)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when PAVmed files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Intelligent Bio Solutions INBS public float $12M, Dec 31, 2025
  2. PetVivo Holdings PETV public float $12M, Jun 29, 2026
  3. Lyra Therapeutics LYRA public float $11M, Jun 30, 2025
  4. Nexgel NXGL public float $11M, Jun 30, 2025
  5. Envoy Medical COCH public float $13M, Dec 31, 2025